Showing results (101-110 of 132) with videos related to
Sort By:
Pageof 14
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 31, 2015
Clinical Utility of Computed Tomography and Magnetic Resonance Imaging for Diagnosis of Posterior Reversible Encephalopathy Syndrome after Stem Cell Transplantation in Children and AdolescentsChristopher E Dandoy, Luke L Linscott, Stella M Davies, et al.Blood|May 31, 2014
Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a study in children and young adultsSonata Jodele, Stella M Davies, Adam Lane, et al.Bone Marrow Transplantation|September 28, 2019
EASIX and mortality after allogeneic stem cell transplantationThomas Luft, Axel Benner, Tobias Terzer, et al.Transplantation and Cellular Therapy|February 27, 2022
Abnormal Maximal and Submaximal Cardiopulmonary Exercise Capacity in Pediatric Stem Cell Transplant Recipients Despite Normal Standard Echocardiographic Parameters: A Pilot StudyAdam W Powell, Elaine M Urbina, Peace Madueme, et al.BMJ Quality & Safety|November 27, 2015
Rapid cycle development of a multifactorial intervention achieved sustained reductions in central line-associated bloodstream infections in haematology oncology units at a children's hospital: a time series analysisChristopher E Dandoy, Jackie Hausfeld, Laura Flesch, et al.Pediatrics|November 12, 2014
A team-based approach to reducing cardiac monitor alarmsChristopher E Dandoy, Stella M Davies, Laura Flesch, et al.Haematologica|April 4, 2020
Endothelial injury, F-actin and vitamin-D binding protein after hematopoietic stem cell transplant and association with clinical outcomesNathan Luebbering, Sheyar Abdullah, Dana Lounder, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 18, 2016
Healthcare Burden, Risk Factors, and Outcomes of Mucosal Barrier Injury Laboratory-Confirmed Bloodstream Infections after Stem Cell TransplantationChristopher E Dandoy, David Haslam, Adam Lane, et al.British Journal of Haematology|October 17, 2015
Obinutuzumab (GA101) compared to rituximab significantly enhances cell death and antibody-dependent cytotoxicity and improves overall survival against CD20(+) rituximab-sensitive/-resistant Burkitt lymphoma (BL) and precursor B-acute lymphoblastic leukaemia (pre-B-ALL): potential targeted therapy in patients with poor risk CD20(+) BL and pre-B-ALLAradhana Awasthi, Janet Ayello, Carmella Van de Ven, et al.Journal of Thrombosis and Haemostasis : JTH|November 13, 2024
Hemostatic derangements associated with cardiopulmonary bypass predict outcomes in pediatric patients undergoing corrective heart surgeryKevin Todd, Spencer J Hogue, James S Tweddell, et al.Pageof 14